Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Becomes Customer of Third Wave s Drug-Metabolism Assay

NEW YORK, Feb. 12 (GenomeWeb News) - LabCorp has become an "early adopter" of Third Wave Technologies' new Invader cytochrome P450 2D6 assay panel, Third Wave said on Tuesday. It is Third Wave's first pharmacogenomics product.

LabCorp will use the assay, which is classified into four drug-metabolism categories, to help drug makers predict drug response in subjects.

The panel comprises SNPs, single and multiple base-pair deletions, and whole gene deletions and duplications in the 2D6 gene family.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.